|
| |
Hyperthyroidism is a very common clinical condition. The lifetime
risk has been estimated at up to 5% in women (5). Subtype of hyperthyroidism is mainly
determined by the level of iodine intake in the region. Nodular toxic goitre is most
prevalent in iodine insufficient regions as opposed to diffuse toxic goitre (Graves
disease) in iodine sufficient regions (7). Since surgery for hyperthyroidism is
infrequently used in any part of the world, and since only a minority of patients on
antithyroid drugs (ATD) will remit, it is not surprising that millions of patients have
been treated with 131I since its introduction in the 1940s (1, 5).
|
|